findmyKOL
Clinical trialNCT00709904CompletedPhase 3Interventional

Evaluation of AVE5026 as Compared to Placebo for the Extended Prophylaxis of Venous Thromboembolism in Patients Having Undergone Hip Fracture Surgery

SponsorSanofiEnrollment469Venous Thromboembolism
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Alexander G. Turpie, MD

    HHS-General Hospital, Hamilton, Ontario, Canada

    Study Chair
  • William D. Fisher, MD

    McGill University Health Centre, Montreal, Quebec, Canada

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

16 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Belarus
  • Sanofi-Aventis Administrative Office

    Minsk, Belarus

Canada
  • Sanofi-Aventis Administrative Office

    Laval, Canada

Chile
  • Sanofi-Aventis Administrative Office

    Santiago, Chile

China
  • Sanofi-Aventis Administrative Office

    Shangaï, China

Colombia
  • Sanofi-Aventis Administrative Office

    Bogotá, Colombia

Egypt
  • Sanofi-Aventis Administrative Office

    Cairo, Egypt

India
  • Sanofi-Aventis Administrative Office

    Mumbai, India

Lithuania
  • Sanofi-Aventis Administrative Office

    Vilnius, Lithuania

Mexico
  • Sanofi-Aventis Administrative Office

    México, Mexico

Peru
  • Sanofi-Aventis Administrative Office

    Lima, Peru

Russia
  • Sanofi-Aventis Administrative Office

    Moscow, Russia

South Africa
  • Sanofi-Aventis Administrative Office

    Midrand, South Africa

South Korea
  • Sanofi-Aventis Administrative Office

    Seoul, South Korea

Turkey (Türkiye)
  • Sanofi-Aventis Administrative Office

    Istanbul, Turkey (Türkiye)

Ukraine
  • Sanofi-Aventis Administrative Office

    Kiev, Ukraine

United States
  • Sanofi-Aventis Administrative Office

    Bridgewater, New Jersey, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Jun 2008
Primary completion
31 Jan 2010
Completion
31 Jan 2010
Last update posted
14 Jun 2013
Registered enrollment
469
Registry id
NCT00709904

Cross-registrations

EU-CTR / CTIS (EudraCT)2007-007947-28

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.